Marc Hilmi

1.4k total citations
34 papers, 716 citations indexed

About

Marc Hilmi is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Marc Hilmi has authored 34 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Marc Hilmi's work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Marc Hilmi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Marc Hilmi collaborates with scholars based in France, United States and Belgium. Marc Hilmi's co-authors include Cindy Neuzillet, Laurent Bartholin, Benoı̂t Rousseau, Julien Caldéraro, Fouad Lafdil, Jean–Michel Pawlotsky, Rémy Nicolle, Alice Boilève, Julien Gondin and Rémi Mounier and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Marc Hilmi

30 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Hilmi France 15 421 171 128 128 123 34 716
Nivedita Arora United States 15 297 0.7× 235 1.4× 109 0.9× 103 0.8× 72 0.6× 38 672
Alessandro Iaculli Italy 10 252 0.6× 133 0.8× 45 0.4× 93 0.7× 76 0.6× 17 517
Kun-Ming Rau Taiwan 14 335 0.8× 194 1.1× 53 0.4× 78 0.6× 125 1.0× 23 724
Feyyaz Özdemir Türkiye 13 217 0.5× 118 0.7× 95 0.7× 71 0.6× 97 0.8× 76 587
Jennifer W. Harris United States 13 145 0.3× 395 2.3× 187 1.5× 360 2.8× 91 0.7× 22 851
Natalia Khalaf United States 13 341 0.8× 154 0.9× 223 1.7× 154 1.2× 131 1.1× 38 704
Olga Nigro Italy 11 340 0.8× 173 1.0× 57 0.4× 99 0.8× 168 1.4× 41 643
Federico Nichetti Italy 13 353 0.8× 171 1.0× 92 0.7× 156 1.2× 166 1.3× 47 594
Amy Schmotzer United States 8 207 0.5× 70 0.4× 83 0.6× 23 0.2× 44 0.4× 16 456
Simon Johannes Gairing Germany 13 173 0.4× 143 0.8× 131 1.0× 119 0.9× 126 1.0× 45 714

Countries citing papers authored by Marc Hilmi

Since Specialization
Citations

This map shows the geographic impact of Marc Hilmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Hilmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Hilmi more than expected).

Fields of papers citing papers by Marc Hilmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Hilmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Hilmi. The network helps show where Marc Hilmi may publish in the future.

Co-authorship network of co-authors of Marc Hilmi

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Hilmi. A scholar is included among the top collaborators of Marc Hilmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Hilmi. Marc Hilmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erakky, Amanda, et al.. (2026). Genomic evolution of pancreatic cancer at single-cell resolution. Nature Genetics. 58(2). 355–365.
2.
Pigneur, F., Marc Hilmi, Dewi Vernerey, et al.. (2025). Muscle Loss During First‐Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13595–e13595. 2 indexed citations
3.
Hilmi, Marc, Jérôme Raffenne, Nelson Dusetti, et al.. (2025). Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom‐up approach. The Journal of Pathology. 265(4). 448–461. 3 indexed citations
4.
Hilmi, Marc, Anthony Turpin, Antoine Andremont, et al.. (2024). Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study. Digestive and Liver Disease. 57(1). 89–96. 1 indexed citations
5.
Hilmi, Marc, Maud Kamal, Sophie Vacher, et al.. (2023). Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial. European Journal of Cancer. 183. 152–161. 26 indexed citations
6.
Hilmi, Marc, Matthieu Delaye, Rémy Nicolle, et al.. (2023). The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy. ˜The œLancet. Gastroenterology & hepatology. 8(12). 1129–1142. 25 indexed citations
7.
8.
Hilmi, Marc, Alice Boilève, Arthur Géraud, et al.. (2022). Evaluation of supportive care needs, sexuality and quality of life in phase 1 trials: a prospective monocentric study. Supportive Care in Cancer. 30(12). 9841–9849.
9.
Neuzillet, Cindy, Rémy Nicolle, Jérôme Raffenne, et al.. (2022). Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma. The Journal of Pathology. 258(4). 408–425. 33 indexed citations
10.
Loriot, Yohann, et al.. (2021). Twitter as a Medical Media Among French Young Oncologists: Results from a National Survey. Journal of Cancer Education. 38(1). 319–324. 2 indexed citations
11.
Hilmi, Marc, Jérôme Cros, Francesco Puleo, et al.. (2021). Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma. European Journal of Cancer. 148. 171–180. 3 indexed citations
12.
Tijeras‐Raballand, Annemilaï, Marc Hilmi, Lucile Astorgues‐Xerri, et al.. (2021). Microbiome and pancreatic ductal adenocarcinoma. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101589–101589. 22 indexed citations
13.
Hilmi, Marc, Matthieu Delaye, Philippe Giraud, et al.. (2021). Objectifs, motivations et difficultés des internes en phase socle en oncologie. Bulletin du Cancer. 109(2). 119–129. 3 indexed citations
14.
Hilmi, Marc, et al.. (2020). Professional and psychological impact of COVID-19 pandemic on medical and radiation oncology residents: Results of a national survey. Clinical Cancer Research. 26(18). 1 indexed citations
15.
Hilmi, Marc, Anna Pellat, Aude-Marie Foucaut, et al.. (2020). Nutrition and physical activity professional education in gastrointestinal oncology: a national multidisciplinary survey. BMJ Supportive & Palliative Care. 10(3). 324–330. 8 indexed citations
16.
Cohen, Romain, T. Pudlarz, Marc Hilmi, et al.. (2019). Traitement des cancers colorectaux par immunothérapie : aller au-delà de MSI avec la classification moléculaire (CMS) et la charge mutationnelle. Bulletin du Cancer. 106(2). 151–161. 2 indexed citations
17.
Hilmi, Marc, Benoı̂t Rousseau, Romain Cohen, et al.. (2019). État des lieux et attentes des internes d’oncologie français concernant le post-internat et la recherche : une enquête nationale GERCOR-AERIO. Bulletin du Cancer. 106(5). 407–420. 3 indexed citations
18.
Hilmi, Marc, Angélique Vienot, Benoı̂t Rousseau, & Cindy Neuzillet. (2019). Immune Therapy for Liver Cancers. Cancers. 12(1). 77–77. 33 indexed citations
19.
Hilmi, Marc, Anne Jouinot, Robert Burns, et al.. (2018). Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?. Pharmacology & Therapeutics. 196. 135–159. 103 indexed citations
20.
Hilmi, Marc, Laurent Bartholin, & Cindy Neuzillet. (2018). Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?. World Journal of Gastroenterology. 24(20). 2137–2151. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nivedita Arora Breakdown of academic impact, for papers by Alessandro Iaculli Breakdown of academic impact, for papers by Kun-Ming Rau Breakdown of academic impact, for papers by Feyyaz Özdemir Breakdown of academic impact, for papers by Jennifer W. Harris Breakdown of academic impact, for papers by Natalia Khalaf Breakdown of academic impact, for papers by Olga Nigro Breakdown of academic impact, for papers by Federico Nichetti Breakdown of academic impact, for papers by Amy Schmotzer Breakdown of academic impact, for papers by Simon Johannes Gairing
Rankless by CCL
2026